Related Experiment Video

Updated: Apr 27, 2026

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

34.5K

Characterization of five newly isolated bacteriophages active against Pseudomonas aeruginosa clinical strains

Magdalena Kwiatek1, Lidia Mizak, Sylwia Parasion

  • 1Biological Threat Identification and Countermeasure Centre, Military Institute of Hygiene and Epidemiology, Lubelska 2, 24-100, Puławy, Poland, magda.kwiatek09@gmail.com.

Folia Microbiologica
|July 5, 2014
PubMed

Insights

New bacteriophages show promise for treating Pseudomonas aeruginosa infections. These phages offer a potential alternative to antibiotics due to their specificity and safety profile in early studies.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biotechnology

Background:

  • Pseudomonas aeruginosa is a significant opportunistic pathogen causing severe infections, particularly in immunocompromised individuals.
  • Increasing antibiotic resistance in P. aeruginosa necessitates the development of novel therapeutic strategies.
  • Bacteriophage therapy is emerging as a viable alternative due to its specificity and favorable safety profile.

Purpose of the Study:

  • To characterize newly isolated bacteriophages targeting Pseudomonas aeruginosa.
  • To evaluate their potential as candidates for phage therapy.

Main Methods:

  • Isolation and purification of five novel P. aeruginosa phages (vB_PaeM_WP1-WP4 and vB_PaeP_WP5).
  • Characterization of phage host range, genome size, structural proteins, and stability under various conditions.
  • Assessment of Myoviridae and Podoviridae family representatives.

Main Results:

  • Five distinct bacteriophages effective against P. aeruginosa were identified.
  • Preliminary data on host range, genome, proteins, and stability were obtained.
  • The isolated phages belong to the Myoviridae and Podoviridae families.

Conclusions:

  • The newly characterized P. aeruginosa phages demonstrate potential for therapeutic applications.
  • These findings support the further investigation of these bacteriophages in phage therapy protocols.
  • Phage therapy presents a promising avenue for combating P. aeruginosa infections.

More Related Videos

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants11:35

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants

Published on: May 4, 2018

7.6K
Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos11:20

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

5.9K

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
944
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
60.0K
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
70
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
80
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.6K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
85